SLC1A2 and Alzheimer disease: However, whether or not this is true in human disease is uncertain since analysis of postmortem brain from AD cases with significant amyloid and tau pathology showed higher levels of astrocytic EAAT2 in comparison with non-demented cases carrying AD pathology, pointing towards a mechanism of astrocytic resilience against neuropathological changes in AD [112].